XM does not provide services to residents of the United States of America.
F
F

Fresenius

News

ASML Holding, Aviva, HSBC

EUROPE RESEARCH ROUNDUP-ASML Holding, Aviva, HSBC Nov 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ASML Holding, Aviva, and HSBC on Friday. HIGHLIGHTS * ASML Holding NV ASML.AS : Jefferies raises target price to EUR 840 from EUR 760 * Aviva AV.L : HSBC raises to buy from hold * CVC Capital Partners Plc CVC.AS : Citigroup cuts to neutral from buy * HSBC HSBA.L : JP Morgan raises target price to 730p from 700p * Spirax Group SP
3
A
A
A
B
B
D
D
E
E
E
E
E
F
H
H
K
N
A
A
G
J

Anima Holding, BASF, Cargotec

EUROPE RESEARCH ROUNDUP-Anima Holding, BASF, Cargotec Nov 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anima Holding, BASF and Cargotec on Monday. HIGHLIGHTS * Anima Holding ANIM.MI : HSBC cuts to hold from buy * BASF SE BASFn.DE : Goldman Sachs raises to buy * Cargotec Corp CGCBV.HE : Kepler Cheuvreux raises to hold from reduce * Compagnie Financiere Richemont SA CFR.S : HSBC raises to buy from hold * DS Smith SMDS.L : Barcl
A
A
A
A
B
B
B
C
D
E
F
F
H
H
I
R
R
S
A
A
B
B
B
C
D
M

Compass Group, Pandora, SSP Group

EUROPE RESEARCH ROUNDUP-Compass Group, Pandora, SSP Group Nov 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Compass Group, Pandora and SSP Group, on Thursday. HIGHLIGHTS * Compass Group CPG.L : Jefferies raises target price to 3,000p from 2,500p * Just Eat Takeaway.Com JETJ.L : JP Morgan raises target price to 1,415p from 1,396p * Marks and Spencer Group MKS.L : JP Morgan raises target price to 440p from 425p * Pandora PNDORA.C
A
B
C
C
E
F
F
G
G
I
K
M
P
P
S
S
S
S
S
Z
A

Fresenius soars on Q3 beat across the board

BUZZ-Fresenius soars on Q3 beat across the board ** German healthcare company Fresenius FREG.DE rises 6.6% after the company reported better-than-expected third-quarter results . ** The company reported a 7% increase in group revenues to 5.3 billion euros and a 8% increase in adjusted EBIT, which came in at 552 million euros. ** The results were "ahead of consensus expectations across the board", Berenberg said ** "The better-than-expected performance was driven by core operating performance and
F
F
G

Fresenius SE Q3 Revenue At EUR 5.30 Bln Versus EUR 5.21 Bln Consensus

BRIEF-Fresenius SE Q3 Revenue At EUR 5.30 Bln Versus EUR 5.21 Bln Consensus Nov 6 (Reuters) - FRESENIUS SE & CO KGAA FREG.DE : Q3 REVENUE AT EUR 5.30 BILLION VERSUS EUR 5.21 BILLION CONSENSUS UPGRADES 2024 OUTLOOK FOR EBIT BEFORE SPECIAL ITEMS GROWTH TO 8%-11% FROM 6%-10% Q3 EBIT BEFORE SPECIAL ITEMS AT EUR 552 MILLION VERSUS EUR 533.8 MILLION CONS
F

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.